Startup based in the United States, most recent round Series-c-plus.
Eversana is a startup based in the United States. Its most recent tracked round is Series-c-plus.
Eversana provides commercialization, market-access, patient-support, consulting, and technology services to biopharma, medical device, and life sciences companies to support product launches and therapy delivery. Its services include market access and reimbursement, distribution, patient services, and data/analytics to optimize commercialization and patient outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.